Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Atrium Therapeutics, Inc. | 20,000 | reported | 27 Feb 2026 | tx 1+20,000 |
| AKCEA THERAPEUTICS, INC. | 19,888 | reported | 15 Jul 2019 | tx 5+1,194,707−1,819 |
| Contineum Therapeutics, Inc. | 14,750 | reported | 26 Jun 2025 | tx 2+44,250 |
| IONIS PHARMACEUTICALS INC | 8,931 | reported | 16 Jan 2018 | tx 25+234,661−15,467 |
| Berkeley Lights, Inc. | 1,400 | reported | 14 May 2021 | tx 7+16,300−20,000 |
| LIGAND PHARMACEUTICALS INC | 0 | reported | 01 Nov 2022 | tx 10+19,256−5,344 |
| Avidity Biosciences, Inc. | 0 | reported | 27 Feb 2026 | tx 91+3,077,000−4,484,578 |
| OmniAb, Inc. | 0 | reported | 18 Jun 2024 | tx 16+384,673−20,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Feb 2026 | GRANT_AWARD | Atrium Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 27 Feb 2026 | OTHER | Avidity Biosciences, Inc. | 474,861 | — | |
| 27 Feb 2026 | OTHER | Avidity Biosciences, Inc. | 386,015 | — | deriv |
| 27 Feb 2026 | OTHER | Avidity Biosciences, Inc. | 300,000 | — | deriv |
| 27 Feb 2026 | OTHER | Avidity Biosciences, Inc. | 425,000 | — | deriv |
| 27 Feb 2026 | OTHER | Avidity Biosciences, Inc. | 165,000 | — | deriv |
| 27 Feb 2026 | OTHER | Avidity Biosciences, Inc. | 200,000 | — | deriv |
| 27 Feb 2026 | OTHER | Avidity Biosciences, Inc. | 300,000 | — | deriv |
| 27 Feb 2026 | OTHER | Avidity Biosciences, Inc. | 400,000 | — | deriv |
| 21 Jan 2026 | SALE | Avidity Biosciences, Inc. | 6,394 | 72.45 USD | |
| 21 Jan 2026 | SALE | Avidity Biosciences, Inc. | 7,993 | 72.45 USD | |
| 07 Jan 2026 | SALE | Avidity Biosciences, Inc. | 8,576 | 72.23 USD | |
| 17 Dec 2025 | GRANT_AWARD | Avidity Biosciences, Inc. | 31,000 | 0.00 USD | |
| 18 Dec 2025 | GIFT | Avidity Biosciences, Inc. | 29,159 | 0.00 USD | |
| 17 Dec 2025 | TAX_WITHHOLDING | Avidity Biosciences, Inc. | 15,742 | 71.87 USD | |
| 05 Sept 2025 | SALE | Avidity Biosciences, Inc. | 50,000 | 49.95 USD | |
| 05 Sept 2025 | EXERCISE | Avidity Biosciences, Inc. | 50,000 | 1.24 USD | |
| 05 Sept 2025 | EXERCISE | Avidity Biosciences, Inc. | 50,000 | 0.00 USD | deriv |
| 28 Aug 2025 | EXERCISE | Avidity Biosciences, Inc. | 25,000 | 1.24 USD | |
| 28 Aug 2025 | SALE | Avidity Biosciences, Inc. | 25,000 | 49.39 USD | |
| 28 Aug 2025 | EXERCISE | Avidity Biosciences, Inc. | 25,000 | 0.00 USD | deriv |
| 26 Jun 2025 | GRANT_AWARD | Contineum Therapeutics, Inc. | 14,750 | 0.00 USD | deriv |
| 20 Mar 2025 | SALE | Avidity Biosciences, Inc. | 31,540 | 31.06 USD | |
| 21 Jan 2025 | SALE | Avidity Biosciences, Inc. | 5,659 | 28.59 USD | |
| 21 Jan 2025 | SALE | Avidity Biosciences, Inc. | 4,738 | 28.59 USD |